Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the offering. Magenta Therapeutics, Inc. executed the $69 million follow-on offering…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now